Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The use of metformin in type 1 diabetes: a systematic review of efficacy.

Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR.

Diabetologia. 2010 May;53(5):809-20. doi: 10.1007/s00125-009-1636-9. Epub 2010 Jan 8. Review.

PMID:
20057994
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
4.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
5.

Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.

Kvapil M, Swatko A, Hilberg C, Shestakova M.

Diabetes Obes Metab. 2006 Jan;8(1):39-48.

PMID:
16367881
7.

Metformin and insulin: is there a role for combination therapy?

Daniel JR, Hagmeyer KO.

Ann Pharmacother. 1997 Apr;31(4):474-80. Review.

PMID:
9101010
9.

Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.

Williams-Herman D, Johnson J, Teng R, Luo E, Davies MJ, Kaufman KD, Goldstein BJ, Amatruda JM.

Curr Med Res Opin. 2009 Mar;25(3):569-83. doi: 10.1185/03007990802705679 .

PMID:
19232032
10.

The insulin-sparing effect of metformin in insulin-treated diabetic patients.

Golay A, Guillet-Dauphiné N, Fendel A, Juge C, Assal JP.

Diabetes Metab Rev. 1995 Sep;11 Suppl 1:S63-7. Review. No abstract available.

PMID:
8529487
11.

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu PL, Braceras R, Wynne A.

Diabetes Obes Metab. 2009 Jan;11(1):27-32. Epub 2007 Oct 17.

PMID:
17941873
12.

Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.

Setter SM, Iltz JL, Thams J, Campbell RK.

Clin Ther. 2003 Dec;25(12):2991-3026. Review.

PMID:
14749143
13.

Pioglitazone is effective therapy for elderly patients with type 2 diabetes mellitus.

Rajagopalan R, Perez A, Ye Z, Khan M, Murray FT.

Drugs Aging. 2004;21(4):259-71.

PMID:
15012171
14.

Metformin and insulin in type 1 diabetes: the first step.

Meyer L, Guerci B.

Diabetes Care. 2003 May;26(5):1655-6. No abstract available.

PMID:
12716857
15.
16.

Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus.

Urakami T, Morimoto S, Owada M, Harada K.

Pediatr Int. 2005 Aug;47(4):430-3.

PMID:
16091082
17.

Metformin use as an adjunct to insulin treatment.

Gunton JE, Twigg SM.

Med J Aust. 2003 Jun 2;178(11):591-2. No abstract available.

PMID:
12765513
18.

Inhaled dry powder insulin for the treatment of diabetes mellitus.

Setter SM, Levien TL, Iltz JL, Odegard PS, Neumiller JJ, Baker DE, Campbell RK.

Clin Ther. 2007 May;29(5):795-813. Review.

PMID:
17697900
19.

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH; Lispro Mixture-Glargine Study Group.

Clin Ther. 2004 Dec;26(12):2034-44. Erratum in: Clin Ther. 2005 Jul;27(7):1112.

PMID:
15823767
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk